177
Views
31
CrossRef citations to date
0
Altmetric
Original Research

A nationwide study of the epidemiology of relapsing polychondritis

, , , , , & show all
Pages 211-230 | Published online: 23 Jun 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Roberto Padoan, Debora Campaniello, Luca Iorio, Andrea Doria & Franco Schiavon. (2022) Biologic therapy in relapsing polychondritis: navigating between options. Expert Opinion on Biological Therapy 22:5, pages 661-671.
Read now
Fernando Kemta Lekpa & Xavier Chevalier. (2018) Refractory relapsing polychondritis: challenges and solutions. Open Access Rheumatology: Research and Reviews 10, pages 1-11.
Read now
Jonas F Ludvigsson & Ronald van Vollenhoven. (2016) Prevalence and comorbidity of relapsing polychondritis. Clinical Epidemiology 8, pages 361-362.
Read now

Articles from other publishers (28)

Yongmei Liu, Xiaomeng Li, Linlin Cheng, Haoting Zhan, Yuan Huang, Haolong Li & Yongzhe Li. (2023) Progress and challenges in the use of blood biomarkers in relapsing polychondritis. Clinical and Experimental Immunology 212:3, pages 199-211.
Crossref
Kornelis S.M. van der Geest, Berend G.C. Slijkhuis, Alessandro Tomelleri, Olivier Gheysens, William F. Jiemy, Costanza Piccolo, Pieter Nienhuis, Maria Sandovici, Elisabeth Brouwer, Andor W.J.M. Glaudemans, Douwe J. Mulder & Riemer H.J.A. Slart. (2023) Positron Emission Tomography Imaging in Vasculitis. Cardiology Clinics 41:2, pages 251-265.
Crossref
Rafael A. Ríos-Rivera & Luis M. Vilá. (2023) Coexistent Relapsing Polychondritis and Clinically Amyopathic Dermatomyositis: A Rare Association of Autoimmune Disorders. Case Reports in Rheumatology 2023, pages 1-5.
Crossref
T. Papo. (2023) Policondritis atrofiante. EMC - Tratado de Medicina 27:1, pages 1-5.
Crossref
T. Papo. (2023) Policondrite atrofizzante. EMC - AKOS - Trattato di Medicina 25:1, pages 1-5.
Crossref
Mohamed-Yacine Khitri, Alexis F Guedon, Sophie Georgin-Lavialle, Benjamin Terrier, David Saadoun, Julie Seguier, Maelle le Besnerais, Claire De Moreuil, Guillaume Denis, Mathieu Gerfaud-Valentin, Jean Sebastien Allain, Alexandre Maria, Laurence Bouillet, Vincent Grobost, Joris Galland, Olivier Kosmider, Anael Dumont, Mathilde Devaux, Benjamin Subran, Jean Schmidt, Paola Marianetti-Guingel, Sylvain Audia, Sylvain Palat, Marielle Roux-Sauvat, Vincent Jachiet, Pierre Hirsch, Olivier Fain & Arsène Mekinian. (2022) Comparison between idiopathic and VEXAS-relapsing polychondritis: analysis of a French case series of 95 patients. RMD Open 8:2, pages e002255.
Crossref
Toyoshi Yanagihara, Migiwa Ohgushi, Taro Setoguchi, Naruhiko Ogo, Yu Inutsuka, Haruna Fujiwara, Tatsuma Asoh, Syunya Sunami, Reiko Yoneda & Takashige Maeyama. (2022) Early Recognition and Treatment of Relapsing Polychondritis. Cureus.
Crossref
Jun Shimizu, Yoshihisa Yamano, Kimito Kawahata & Noboru Suzuki. (2022) Nationwide cross-sectional survey of patients with relapsing polychondritis in 2019 demonstrates reduction of airway involvement compared with that in 2009. Scientific Reports 12:1.
Crossref
Xiaoyu Cao, Mengzhu Zhao, Huijuan Li, Dong Xu, Mengtao Li, Xuan Zhang, Fengchun Zhang, Yong Hou & Xiaofeng Zeng. (2021) Three new inflammatory markers C reactive protein to albumin ratio, neutrophil to lymphocyte ratio, and platelet to lymphocyte ratio correlated with relapsing polychondritis disease activity index. Clinical Rheumatology 40:11, pages 4685-4691.
Crossref
Trishul Kothari, Theodoros Valsamakis, Arani V Sridhar & Molla Imaduddin Ahmed. (2021) Case of paediatric relapsing polychondritis with severe airway involvement: the challenges of long-term airway and respiratory management. BMJ Case Reports 14:8, pages e239774.
Crossref
Judith Leyens, Tim Th. A. Bender, Martin Mücke, Christiane Stieber, Dmitrij Kravchenko, Christian Dernbach & Matthias F. Seidel. (2021) The combined prevalence of classified rare rheumatic diseases is almost double that of ankylosing spondylitis. Orphanet Journal of Rare Diseases 16:1.
Crossref
Tamás Ferenci. (2021) Different approaches to quantify years of life lost from COVID-19. European Journal of Epidemiology 36:6, pages 589-597.
Crossref
Rob van Kimmenaede, Leida Zwart-Reijnders & Onno ten Berge. (2021) Rooie oortjes. Huisarts en wetenschap 64:2, pages 51-52.
Crossref
Hye-In Jung, Hyun Jung Kim, Ji-Min Kim, Ju Yup Lee, Kyung Sik Park, Kwang Bum Cho & Yoo Jin Lee. (2021) Co-existence of relapsing polychondritis and Crohn disease treated successfully with infliximab. Yeungnam University Journal of Medicine 38:1, pages 70-73.
Crossref
Shirish Dubey, Colin Gelder, Grace Pink, Asad Ali, Christopher Taylor, Joanna Shakespeare, Susan Townsend, Patrick Murphy, Nicholas Hart & David D'Cruz. (2021) Respiratory subtype of relapsing polychondritis frequently presents as difficult asthma: a descriptive study of respiratory involvement in relapsing polychondritis with 13 patients from a single UK centre. ERJ Open Research 7:1, pages 00170-2020.
Crossref
Xiaoyu Cao, Lixiu Zhu, Huijuan Li, Li Jiang, Dong Xu, Jiuliang Zhao, Jiaxin Zhou, Fengchun Zhang, Yong Hou & Xiaofeng Zeng. (2021) Comparison of relapsing polychondritis patients with and without central nervous system involvement: A retrospective study of 181 patients. International Journal of Immunopathology and Pharmacology 35, pages 205873842110005.
Crossref
David P. D’Cruz & Marcela A. Ferrada. (2020) Relapsing Polychondritis and Large-vessel Vasculitis. The Journal of Rheumatology 47:12, pages 1732-1733.
Crossref
Sheng‐Yuan Wang, Chia‐Tse Weng, Lili Cheng & Tang‐Hsiu Huang. (2020) Relapsing polychondritis with isolated tracheal involvement and airway‐only symptoms. Respirology Case Reports 8:7.
Crossref
Filka Georgieva & Sonya Marina. (2019) Relapsing polychondritis. A case report and brief introduction to the disease. Scripta Scientifica Medica 51:4, pages 31.
Crossref
Beata Maciążek-Chyra, Magdalena Szmyrka, Marta Skoczyńska, Renata Sokolik, Joanna Lasocka & Piotr Wiland. (2019) Relapsing polychondritis – analysis of symptoms and criteria. Rheumatology 57:1, pages 8-18.
Crossref
Simona Rednic, Laura Damian, Rosaria Talarico, Carlo Alberto Scirè, Alexander Tobias, Nathalie Costedoat-Chalumeau, David Launay, Alexis Mathian, Lisa Matthews, Cristina Ponte, Paola Toniati, Stefano Bombardieri, Charissa Frank, Matthias Schneider, Vanessa Smith, Maurizio Cutolo, Marta Mosca & Laurent Arnaud. (2018) Relapsing polychondritis: state of the art on clinical practice guidelines. RMD Open 4:Suppl 1, pages e000788.
Crossref
Yamini Krishnan & Alan J. Grodzinsky. (2018) Cartilage diseases. Matrix Biology 71-72, pages 51-69.
Crossref
Alexander Zheutlin & Elena Schiopu. (2018) Relapsing Polychondritis following Treatment with Secukinumab for Ankylosing Spondylitis: Case Report and Review of the Literature. Case Reports in Rheumatology 2018, pages 1-4.
Crossref
J. Dion, G. Leroux, L. Mouthon, J.-C. Piette & N. Costedoat-Chalumeau. (2018) Polychondrite atrophiante : actualités en 2017. La Revue de Médecine Interne 39:6, pages 400-407.
Crossref
Gergely Palla, Nóra Páll, Anna Horváth, Katalin Molnár, Bálint Tóth, Tamás Kováts, György Surján, Tamás Vicsek & Péter Pollner. (2018) Complex clinical pathways of an autoimmune disease. Journal of Complex Networks 6:2, pages 206-214.
Crossref
Dennis W. Wolff. 2018. Reference Module in Biomedical Sciences. Reference Module in Biomedical Sciences.
Daniel Cuestas, Elkin Peñaranda, Sergio Mora, Carolina Cortes, Ingrid Galvis, Mónica Patiño & Oscar Velasquez. (2017) Relapsing polychondritis, an underestimated dermatological urgency: case report and literature review. International Journal of Dermatology 56:12, pages 1379-1386.
Crossref
B. Hofauer, A. Chaker, K. Thürmel & A. Knopf. (2017) Manifestationen von Autoimmunerkrankungen in der HNO-HeilkundeManifestations of autoimmune disorders in otorhinolaryngology. HNO 65:8, pages 695-708.
Crossref